- Home
- ZNTL vs ANIK Comparison
ZNTL vs ANIK Comparison
Compare ZNTL & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- ANIK
- Stock Information
- Founded
- ZNTL 2014
- ANIK 1983
- Country
- ZNTL United States
- ANIK United States
- Employees
- ZNTL N/A
- ANIK N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- ANIK Medical/Dental Instruments
- Sector
- ZNTL Health Care
- ANIK Health Care
- Exchange
- ZNTL Nasdaq
- ANIK Nasdaq
- Market Cap
- ZNTL 118.3M
- ANIK 133.1M
- IPO Year
- ZNTL 2020
- ANIK 1993
- Fundamental
- Price
- ZNTL $1.53
- ANIK $9.68
- Analyst Decision
- ZNTL Buy
- ANIK Buy
- Analyst Count
- ZNTL 6
- ANIK 1
- Target Price
- ZNTL $6.53
- ANIK $15.00
- AVG Volume (30 Days)
- ZNTL 751.6K
- ANIK 97.9K
- Earning Date
- ZNTL 11-06-2025
- ANIK 11-05-2025
- Dividend Yield
- ZNTL N/A
- ANIK N/A
- EPS Growth
- ZNTL N/A
- ANIK N/A
- EPS
- ZNTL N/A
- ANIK N/A
- Revenue
- ZNTL $26,865,000.00
- ANIK $114,548,000.00
- Revenue This Year
- ZNTL N/A
- ANIK N/A
- Revenue Next Year
- ZNTL N/A
- ANIK $4.57
- P/E Ratio
- ZNTL N/A
- ANIK N/A
- Revenue Growth
- ZNTL N/A
- ANIK 16.52
- 52 Week Low
- ZNTL $1.01
- ANIK $7.87
- 52 Week High
- ZNTL $4.44
- ANIK $24.85
- Technical
- Relative Strength Index (RSI)
- ZNTL 44.74
- ANIK 56.36
- Support Level
- ZNTL $1.49
- ANIK $9.59
- Resistance Level
- ZNTL $1.82
- ANIK $10.17
- Average True Range (ATR)
- ZNTL 0.11
- ANIK 0.35
- MACD
- ZNTL 0.00
- ANIK 0.05
- Stochastic Oscillator
- ZNTL 11.43
- ANIK 67.30
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.